Komori
Bando Chemical Industries (5195) · InitiativeAdvanced

Creating New Businesses and Developing New Markets

First written in FY2016. 30 of 35 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-07.

35entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY2022AdvancedFY2023-Q3 – FY20252016: 220162017: 320172018: 420182019: 420192020: 320202021: 320212022: 320222023: 320232024: 320242025: 220252026: 52026
Same theme, other companies
Market expansion through new technologies, products and servicesA theme 58 companies write about · 0 as a headwind · 59 as a tailwind

37 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「As a product contributing to carbon neutrality, the Company began test sales in July 2025 of Silver Arrow®, an outdoor radiative-cooling film that contributes to energy savings and uses the Company’s proprietary film-processing technology.」

    The Company began test sales in July 2025 of Silver Arrow®, an outdoor radiative-cooling film using its proprietary film-processing technology for energy-saving applications.
  2. FY2026-H1WorsenedAnnual report

    「The Other businesses comprise the robot-related devices, Electronic Materials and medical device businesses, among others. Revenue was ¥3,151 million, up 8.0% year on year, and segment profit was ¥81 million, down 50.1% year on year.」

    Other businesses, including robot-related devices, Electronic Materials and medical devices, posted higher revenue, while segment profit declined 50.1% year on year.
  3. FY2025AdvancedAnnual report

    「In addition to deepening its core businesses, the Company will accelerate the development of new businesses through co-creation with startups, including an investment in inaho and a strategic partnership agreement with Inmotive Inc.」

    Through its investment in inaho and strategic partnership agreement with Inmotive Inc., the Company gave concrete form to co-creation with startups as a means of developing its new and core businesses.
  4. FY2025-H1AdvancedAnnual report

    「The Other businesses comprise the robot-related devices, Electronic Materials and medical device businesses, among others. Revenue was ¥2,917 million, up 10.8% year on year, and segment profit was ¥164 million, compared with a segment loss of ¥47 million in the same period of the previous year.」

    Revenue from Other businesses, including new businesses, increased, and the segment turned around from a loss in the same period of the previous year to profit of ¥164 million.
  5. FY2024AdvancedAnnual report

    「The Company will also continue sales-expansion activities and promote the commercialization of e=Bone®, an absorbable material for bone regeneration developed through industry-academia collaboration and based on the Group’s core technologies.」

    It stated that, following the launch of e=Bone®, the result of industry-academia collaboration, in the previous fiscal year, it would continue sales expansion and commercialization efforts.
  6. FY2024-Q3AdvancedAnnual report

    「The company began selling Pull-Out Alert®, a healthcare device that detects removal motions and uses its proprietary C-STRETCH® stretchable strain sensor.」

    The Company began selling Nukeru Alert®, a healthcare device applying C-STRETCH®, giving concrete form to the development of new businesses and markets.
  7. FY2024-Q1AdvancedAnnual report

    「As a new addition to the Sunline® Belt light-duty conveyor-belt lineup, the company began selling Mister Porters™, a logistics-conveyance belt with excellent low-noise performance.」

    The Company gave concrete form to the creation of new products and development of new applications by beginning sales of a new product for logistics and material-handling applications.
  8. FY2023AdvancedAnnual report

    「The Company also commercialized an absorbable material for bone regeneration developed using the results of industry-academia collaborative research.」

    The Company commercialized an absorbable material for bone regeneration using the results of industry-academia collaborative research, advancing the commercialization of a new business.
  9. FY2023-Q3AdvancedAnnual report

    「The company completed development of Wiltia™ Sheet, a water-repellent and water-permeable sheet for concrete formwork designed to conserve resources by using its proprietary water-repellent technology, and began test sales in November 2022. It also developed Ceptor®-Ⅹ S3M/S5M, a new toothed belt in the Ceptor® series with higher transmission capacity and modulus of elasticity than existing products, providing high power transmission, heavy-load capability and high responsiveness.」

    As specific examples of creating new products and developing new markets, it cites the start of test sales of sheets for concrete formwork and the development of a high-load toothed belt.
  10. FY2023-Q2WorsenedAnnual report

    「The Other businesses comprise the robot-related devices, Electronic Materials and medical device businesses, among others. Revenue was ¥2,449 million, down 5.1% year on year, while the segment recorded a loss of ¥12 million, compared with segment profit of ¥147 million in the same period of the previous year, partly due to the impact of lower reimbursement prices for core products in the medical device business.」

    Revenue from Other businesses, including new businesses, declined 5.1% year on year, and the segment swung to a loss partly due to lower reimbursement prices in the medical device business.
  11. FY2022AdvancedAnnual report

    「Specifically, in the medical device and healthcare device businesses, the Company will leverage Aimedic MMT’s medical device business platform and sales capabilities to accelerate the commercialization of the extensible strain sensor C-STRETCH®, including ResMo® (ResMo), the first medical device in the respiratory field launched during the fiscal year, and the swallowing-motion monitor B4S™ (B4S). At the same time, the Company will create synergies with the Group’s proprietary core technologies and continue developing new products one after another to drive further expansion.」

    The Company launched ResMo® and B4S™, products applying C-STRETCH®, giving concrete form to the commercialization of medical and healthcare devices by leveraging Aimedic MMT’s business platform.
  12. FY2022-Q3AdvancedAnnual report

    「Amid expectations of growing social needs in the field of swallowing, the company began selling the B4S™ swallowing-motion monitor (B4S), a healthcare device using its proprietary C-STRETCH® stretchable strain sensor, as a new product.」

    As part of giving concrete form to a new business, the Company began selling B4S™, a healthcare device applying C-STRETCH®.
  13. FY2022-Q1AdvancedAnnual report

    「In the medical device field, one of the new business pillars the Company has pursued, its consolidated subsidiary Aimedic MMT developed and began selling ResMo, a medical device that applies the technology of C-STRETCH®, an extensible strain sensor independently developed by the Company, through distributors.」

    The Company developed ResMo, a medical device applying C-STRETCH®, and began selling it through distributors.
  14. FY2021AdvancedAnnual report

    「In the Electronic Materials business, the Company worked to expand the market share of TOPX®, a precision polishing material, in the display field, where displays with glass substrates are in mass production, while actively pursuing new demand in areas including storage.」

    For TOPX®, the Company pursued market-share expansion in the display field and developed new demand in areas including storage, giving concrete form to the rollout of new businesses and markets.
  15. FY2021-Q3AdvancedAnnual report

    「In the medical device field, one of the new business pillars the Company has pursued, its consolidated subsidiary Aimedic MMT developed and began selling the AT Measure, which applies the technology of C-STRETCH®, an extensible strain sensor independently developed by the Company. In addition, as the spread of the novel coronavirus resurged and face-to-face communication became restricted, the Company actively held online seminars introducing new products and technologies and helping to resolve issues in various industries.」

    In the medical device field, the Company began selling the AT Measure, which applies C-STRETCH®, and actively held online seminars to promote new products and technologies.
  16. FY2021-Q2AdvancedAnnual report

    「We also began selling “Mr. Silky Touch™,” a non-adhesive belt for food applications with excellent release and slip properties on the belt surface, and “TeClear® EGS-T,” a thin polyethylene film for building and interior materials that reduces CO2 emissions and waste over its lifecycle from manufacture through disposal,」

    As specific new products related to developing new businesses and markets, it cites the launch of sales of Mr. Silky Touch™ and TeClear® EGS-T.
  17. FY2020AdvancedAnnual report

    「Under “Creating New Businesses,” the Company made Aimedic MMT, which develops distinctive products in the medical field, a subsidiary and established a structure to accelerate product development by leveraging its business platform.」

    It states that the Company established a structure to accelerate product development in the medical device and healthcare fields by leveraging Aimedic MMT’s business platform.
  18. FY2020-Q3AdvancedAnnual report

    「Other businesses include the robot-related devices and electronic materials businesses. Following the acquisition of the Medical Devices Business, revenue was ¥3,999 million, up 50.9% year on year.」

    It states that revenue from Other businesses, including the acquisition of Aimedic MMT, was ¥3,999 million for the nine months ended December 31, up 50.9% year on year.
  19. FY2020-Q2AdvancedAnnual report

    「The Group had been working to establish a Medical Devices and Healthcare Equipment Business using the C-STRETCH® stretchable strain sensor as one of its new business pillars. Aimedic MMT has strong brand recognition and sales capabilities in orthopedic medical devices. The company decided to acquire its shares because it determined that the acquisition would enable it to rapidly obtain a medical-business platform and was expected to accelerate the commercialization of C-STRETCH® as a medical device.」

    The company has specified a policy of using Aimedic MMT’s brand recognition and sales capabilities to obtain a medical-business platform and accelerate commercialization, with the aim of establishing a Medical Devices and Healthcare Equipment Business using C-STRETCH®.
  20. FY2020-Q1AdvancedAnnual report

    「To grow its Medical Devices Business as a new business pillar, the Group acquired all shares of Aimedic MMT Co., Ltd. and made it a subsidiary effective 8 May 2019.」

    To grow its Medical Devices Business, the company acquired all shares of Aimedic MMT and made it a subsidiary. Following the acquisition, revenue from Other businesses increased 63.7% year on year.
  21. FY2019AdvancedAnnual report

    「The company will prioritize the allocation of management resources to creating new businesses, centered on the Medical Devices and Healthcare Equipment Business and the Electronic Materials Business, and work to transform its business portfolio. Specifically, in the Medical Devices and Healthcare Equipment Business, it will work to productize and commercialize the C-STRETCH® stretchable strain sensor. In the Electronic Materials Business, it will work to commercialize products including the TOPX® precision abrasive, the Free Crystal® optical clear adhesive sheet, the HEATEX® high-thermal-conductivity heat-dissipation sheet and the FlowMetal® low-temperature-fired metal nanoparticle product. During the consolidated fiscal year, it began mass-production sales of TOPX®, a precision abrasive with excellent grinding performance in the lapping process for glass substrates.」

    The company specified medical and healthcare and electronic materials as priority areas for new businesses and began mass-production sales of TOPX®.
  22. FY2019-Q3AdvancedAnnual report

    「Other businesses include robot-related devices. Sales were ¥2,652 million, up 38.4% year on year, while segment profit was ¥514 million, up 121.4% year on year, helped by growth in the Electronic Materials Business.」

    The company describes sales growth of 38.4% year on year and segment profit growth of 121.4% year on year in Other businesses, including robot-related devices.
  23. FY2019-Q2AdvancedAnnual report

    「To deepen understanding of the potential of its core businesses, which are expected to continue expanding, and the potential of new businesses targeted for early commercialization, the company held Bando Techno Fair 2018 in September.」

    The company held Bando Techno Fair 2018 in September as a venue for presenting the potential of its core businesses and new businesses targeted for early commercialization.
  24. FY2019-Q1AdvancedAnnual report

    「Sales of exterior films for automobiles and motorcycles, for which the company is developing new applications as part of its business transformation, also increased.」

    In the Functional Films Business, the company is developing new applications for exterior films for automobiles and motorcycles and describes an increase in their sales.
  25. FY2018AdvancedAnnual report

    「Under the second stage (BF-2) of the five-year medium- to long-term management plan “Breakthroughs for the future” for 2018 through 2022, the company formulated a new basic strategy making the development of new products created under BF-1 into businesses its highest priority. As the market for automotive belts, the mainstay of its existing businesses, is expected to contract as the shift to electric vehicles progresses, these products include the C-STRETCH® stretchable strain sensor, the HEATEX® high-thermal-conductivity heat-dissipation sheet and the Free Crystal® optical clear adhesive sheet. The Group will work with all its resources to achieve this goal.」

    The company presented a policy of commercializing and nurturing C-STRETCH®, HEATEX® and Free Crystal®, created under BF-1, as the highest-priority initiatives of BF-2.
  26. FY2018-Q3AdvancedAnnual report

    「We also developed “BANDO DEC-20™,” a foreign-material inspection tool that makes falling dust visible, an issue in cleanrooms and similar environments.」

    The company describes the development of BANDO DEC-20™, a foreign-object inspection tool that visualizes airborne dust, as a specific result of creating new businesses and products.
  27. FY2018-Q2AdvancedAnnual report

    「In functional film products, sales of conventional industrial and medical films declined, but sales of exterior films for four-wheel and two-wheel vehicles, toward which the business is being transformed, increased.」

    The company is proceeding with a business transformation toward exterior films for four-wheel and two-wheel vehicles and describes an increase in their sales.
  28. FY2018-Q1AdvancedAnnual report

    「We began selling “LASHINGBITE®,” a tension gauge for lashing belts that enables tension to be measured and managed numerically with high precision, thereby improving transport reliability.」

    The start of sales of the new LASHINGBITE® product represents the specific commercialization of a newly created product.
  29. FY2017AdvancedAnnual report

    「During the fiscal year, amid growing demand for touch panels, the company developed Free Crystal®, an optical clear adhesive sheet with the visibility required particularly for automotive applications, conformability to curved displays and impact resistance.」

    In addition to developing Free Crystal®, the company describes application development for the C-STRETCH® stretchable strain sensor in the nursing-care and health fields.
  30. FY2017-Q1AdvancedAnnual report

    「The company developed products in new business areas, including the optical clear adhesive sheet Free Crystal®.」

    The company describes the development of products such as Free Crystal® in new business areas.
  31. FY2016First statedAnnual report

    「The company will further refine its core technologies in the formulation, dispersion and compounding of rubber, elastomers and resins, and combine these core technologies with new technologies to create new products and develop new markets, nurturing them as the pillars of its next-generation businesses.」

    The company plans to combine new technologies with its existing materials and processing technologies and develop new products and markets as the pillars of its next businesses.
Moved together

"Evolution of the Global Market Strategy" moved the same way as this thread, in the same document, in 25 of its 35 moves.

252315141311★123456
  1. ★This thread
  2. 1Evolution of the Global Market Strategy25×
  3. 2Development of Market-Optimized Specifications and High-Value-Added Products23×
  4. 3Sustaining Innovation and Disruptive Innovation15×
  5. 4Expansion of the Medical Devices Business through the Acquisition of Aimedic MMT14×
  6. 5Flexible capital policy through share repurchases13×
  7. 6Globally Optimized Production Structure and Global Cost Competitiveness11×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Bando Chemical Industries yet. It last moved in the Financial Results Presentation of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Creating New Businesses and Developing New Markets | Bando Chemical Industries,Ltd. (5195) | Komori